InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AbCellera Biologics Inc.

ABCL Clue Score42
British Columbia, Canada Fiscal year ends December CIK 0001703057
$12.55 +4.37% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $12.55 −15.52% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Dec 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue11.6Operating income−4.1Net income−2.2EPS, diluted−0.01Fiscal year 2020Revenue233.2 +1,907.9%Operating income156.0Net income118.9EPS, diluted0.45Fiscal year 2021Revenue375.2 +60.9%Operating income204.4Net income153.5 +29.1%EPS, diluted0.48Fiscal year 2022Revenue485.4 +29.4%Operating income216.5Net income158.5 +3.3%EPS, diluted0.50Fiscal year 2023Revenue38.0 −92.2%Operating income−237.2Net income−146.4 −192.4%EPS, diluted−0.51Fiscal year 2024Revenue28.8 −24.2%Operating income−314.8Net income−162.9EPS, diluted−0.55Fiscal year 2025Revenue75.1 +160.6%Operating income−217.1Net income−146.4EPS, diluted−0.49
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 11.6 233.2 375.2 485.4 38.0 28.8 75.1
Growth +1,907.9% +60.9% +29.4% −92.2% −24.2% +160.6%
Operating income −4.1 156.0 204.4 216.5 −237.2 −314.8 −217.1
Net income −2.2 118.9 153.5 158.5 −146.4 −162.9 −146.4
Growth +29.1% +3.3% −192.4%
EPS, diluted −0.01 0.45 0.48 0.50 −0.51 −0.55 −0.49

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−35.5%Net margin−19.0%Free cash flow margin−11.2%Fiscal year 2020Operating margin66.9%Net margin51.0%Free cash flow margin5.6%Fiscal year 2021Operating margin54.5%Net margin40.9%Free cash flow margin49.6%Fiscal year 2022Operating margin44.6%Net margin32.7%Free cash flow margin42.6%Fiscal year 2023Operating margin−623.8%Net margin−385.0%Free cash flow margin−317.7%Fiscal year 2024Operating margin−1,091.7%Net margin−564.8%Free cash flow margin−648.4%Fiscal year 2025Operating margin−289.0%Net margin−194.9%Free cash flow margin−231.7%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −35.5% 66.9% 54.5% 44.6% −623.8% −1,091.7% −289.0%
Net margin −19.0% 51.0% 40.9% 32.7% −385.0% −564.8% −194.9%
Free cash flow margin −11.2% 5.6% 49.6% 42.6% −317.7% −648.4% −231.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow2.7Capital expenditure−4.0Free cash flow−1.3Fiscal year 2020Operating cash flow22.7Capital expenditure−9.7Free cash flow13.0Fiscal year 2021Operating cash flow244.6Capital expenditure−58.5Free cash flow186.1 +1,329.9%Fiscal year 2022Operating cash flow277.4Capital expenditure−70.7Free cash flow206.7 +11.1%Fiscal year 2023Operating cash flow−43.9Capital expenditure−76.9Free cash flow−120.8 −158.5%Fiscal year 2024Operating cash flow−108.6Capital expenditure−78.4Free cash flow−187.0Fiscal year 2025Operating cash flow−131.3Capital expenditure−42.8Free cash flow−174.1
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 2.7 22.7 244.6 277.4 −43.9 −108.6 −131.3
Capital expenditure −4.0 −9.7 −58.5 −70.7 −76.9 −78.4 −42.8
Free cash flow −1.3 13.0 186.1 206.7 −120.8 −187.0 −174.1
Growth +1,329.9% +11.1% −158.5%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Shareholders’ equity10.3Fiscal year 2020Cash594.1Total debt0.2Net cash (debt)593.9Shareholders’ equity830.5Debt to equity0.00Fiscal year 2021Cash476.1Shareholders’ equity1,025.7Fiscal year 2022Cash386.5Shareholders’ equity1,233.3Fiscal year 2023Cash133.3Shareholders’ equity1,152.3Fiscal year 2024Cash156.3Shareholders’ equity1,056.1Fiscal year 2025Cash128.5Shareholders’ equity966.9
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash n/a 594.1 476.1 386.5 133.3 156.3 128.5
Total debt n/a 0.2 n/a n/a n/a n/a n/a
Net cash (debt) n/a 593.9 n/a n/a n/a n/a n/a
Shareholders’ equity 10.3 830.5 1,025.7 1,233.3 1,152.3 1,056.1 966.9
Debt to equity n/a 0.00 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
n/a 594.1 476.1 386.5 133.3 156.3 128.5
n/a 0.9 n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a 0.0 6.3
n/a 17.9 111.6 217.3 n/a n/a n/a
n/a 31.5 47.8 47.8 47.8 47.8 47.8
n/a 1,005.5 1,318.6 1,540.9 1,488.1 1,360.6 1,357.0
Growth +31.1% +16.9% −3.4% −8.6% −0.3%
Liabilities
n/a 0.2 n/a n/a n/a n/a n/a
calc n/a 0.2 n/a n/a n/a n/a n/a
n/a 175.0 292.8 307.6 335.8 304.5 390.0
Equity
n/a 114.2 267.7 426.2 279.8 116.9 −29.5
10.3 830.5 1,025.7 1,233.3 1,152.3 1,056.1 966.9
Growth +8,000.9% +23.5% +20.2% −6.6% −8.4% −8.4%
Per share and net cash
calc n/a 593.9 n/a n/a n/a n/a n/a
n/a 269.5 283.3 286.9 290.8 295.8 300.6
calc n/a 3.08 3.62 4.30 3.96 3.57 3.22

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.